Login / Signup
Lisa Griffioen
ORCID
Publication Activity (10 Years)
Years Active: 2023-2024
Publications (10 Years): 5
Top Topics
Transforming Growth Factor
Zika Virus
Tyrosine Kinase
Low Dose
Top Venues
Cancer immunology research
Cancer research communications
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Christianne Groeneveldt
,
Priscilla Kinderman
,
Lisa Griffioen
,
Olivia Rensing
,
Camilla Labrie
,
Diana J M van den Wollenberg
,
Wytske M van Weerden
,
Matthew Coffey
,
Houra Loghmani
,
Elizabeth M E Verdegaal
,
Marij J P Welters
,
Sjoerd H Van der Burg
,
Thorbald van Hall
,
Nadine van Montfoort
Neutralizing antibodies impair the oncolytic efficacy of reovirus but permit effective combination with T cell-based immunotherapies.
Cancer immunology research
(2024)
Christianne Groeneveldt
,
Priscilla Kinderman
,
Lisa Griffioen
,
Olivia Rensing
,
Camilla Labrie
,
Diana J M van den Wollenberg
,
Wytske M van Weerden
,
Matthew Coffey
,
Houra Loghmani
,
Elizabeth M E Verdegaal
,
Marij J P Welters
,
Sjoerd H Van der Burg
,
Thorbald van Hall
,
Nadine van Montfoort
Neutralizing Antibodies Impair the Oncolytic Efficacy of Reovirus but Permit Effective Combination with T cell-Based Immunotherapies.
Cancer immunology research
12 (3) (2024)
Christianne Groeneveldt
,
Priscilla Kinderman
,
Lisa Griffioen
,
Olivia Rensing
,
Camilla Labrie
,
Diana J M van den Wollenberg
,
Wytske M van Weerden
,
Matthew Coffey
,
Houra Loghmani
,
Elizabeth M E Verdegaal
,
Marij J P Welters
,
Sjoerd H Van der Burg
,
Thorbald van Hall
,
Nadine van Montfoort
Neutralizing Antibodies Impair the Oncolytic Efficacy of Reovirus but Permit Effective Combination with T cell-Based Immunotherapies.
Cancer immunology research
12 (3) (2024)
Christianne Groeneveldt
,
Jurriaan Q van Ginkel
,
Priscilla Kinderman
,
Marjolein Sluijter
,
Lisa Griffioen
,
Camilla Labrie
,
Diana J M van den Wollenberg
,
Wytske M van Weerden
,
Sjoerd H Van der Burg
,
Peter Ten Dijke
,
Lukas J A C Hawinkels
,
Thorbald van Hall
,
Nadine van Montfoort
Intertumoral Differences Dictate the Outcome of TGF-β Blockade on the Efficacy of Viro-Immunotherapy.
Cancer research communications
3 (2) (2023)
Christianne Groeneveldt
,
Jurriaan Q van Ginkel
,
Priscilla Kinderman
,
Marjolein Sluijter
,
Lisa Griffioen
,
Camilla Labrie
,
Diana J M van den Wollenberg
,
Wytske M van Weerden
,
Sjoerd H Van der Burg
,
Peter Ten Dijke
,
Lukas J A C Hawinkels
,
Thorbald van Hall
,
Nadine van Montfoort
Intertumoral Differences Dictate the Outcome of TGF-β Blockade on the Efficacy of Viro-Immunotherapy.
Cancer research communications
3 (2) (2023)